West Pharmaceutical Services WST Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Proprietary Products | $2.62B+12.2% | $2.49B+6.8% | $2.44B+5.6% | $2.4B+3.6% | $2.34B-1.5% | |
| Other segment expense (income) by Business | ||||||
| Proprietary Products | $21.2M-6.2% | $21.1M-4.5% | $26.9M+91.8% | $26.2M+112% | $22.6M+65.3% | |
| Total Assets by Business | ||||||
| Proprietary Products | $11.74B— | $11.43B— | $11.06B— | —— | —— | |
| Operating Income (Loss) by Business | ||||||
| Proprietary Products | $715.8M+23.0% | $657.2M+13.7% | $629.8M+8.8% | $612.8M+1.7% | $582.1M-12.6% | |
| Selling, general and administrative expenses by Business | ||||||
| Proprietary Products | $260.3M+12.6% | $255.6M+10.4% | $245.5M+5.1% | $236.5M-0.3% | $231.1M-4.2% | |
| Cost of goods and services sold by Business | ||||||
| Proprietary Products | $1.55B+8.2% | $1.48B+3.5% | $1.47B+4.2% | $1.45B+4.8% | $1.43B+4.3% | |
| Capital Expenditures by Business | ||||||
| Proprietary Products | $188.9M-20.4% | $204.3M-17.1% | $227.2M-2.1% | $227.3M-8.8% | $237.3M-7.1% | |
| R&D by Business | ||||||
| Proprietary Products | $73.8M+8.8% | $74.3M+7.5% | $71M+4.9% | $69.4M+0.1% | $67.8M-1.6% | |
| Depreciation and Amortization by Business | ||||||
| Proprietary Products | $143.9M+8.2% | $140.2M+7.6% | $135M+8.0% | $133.7M+11.9% | $133M+16.0% | |
| Concentration risk, percentage by Product | ||||||
| Standard Packaging | 52%-7.0pp | 55%+7.0pp | 57%+8.0pp | 61%+17.0pp | 59%+14.0pp | |
| Concentration risk, percentage by Geography | ||||||
| Asia Pacific | 26%— | 25%— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does West Pharmaceutical Services break its business down?
- West Pharmaceutical Services (WST) reports net sales by business across 2 parts — Proprietary Products and West Vantage. Each is extracted from the segment footnotes and tracked over time.
- Where does West Pharmaceutical Services's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in West Pharmaceutical Services's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
